65 related articles for article (PubMed ID: 37300812)
1. TIGIT, a novel immune checkpoint therapy for melanoma.
Tang W; Chen J; Ji T; Cong X
Cell Death Dis; 2023 Jul; 14(7):466. PubMed ID: 37495610
[TBL] [Abstract][Full Text] [Related]
2. Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors.
Olateju OA; Zeng Z; Thornton JD; Mgbere O; Essien EJ
BMC Cancer; 2023 Jul; 23(1):655. PubMed ID: 37442992
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma.
Sharon CE; Tortorello GN; Ma KL; Huang AC; Xu X; Giles LR; McGettigan S; Kreider K; Schuchter LM; Mathew AJ; Amaravadi RK; Gimotty PA; Miura JT; Karakousis GC; Mitchell TC
Ann Oncol; 2023 Sep; 34(9):806-812. PubMed ID: 37414215
[TBL] [Abstract][Full Text] [Related]
4. IFNγ score-based neoadjuvant immunotherapy for stage III melanoma.
Fukuda K
J Exp Med; 2023 May; 220(5):. PubMed ID: 36920330
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant immunotherapy for melanoma is now ready for clinical practice.
Garbe C; Dummer R; Amaral T; Amaria RN; Ascierto PA; Burton EM; Dreno B; Eggermont AMM; Hauschild A; Hoeller C; Kaufmann R; Lebbe C; Mandala M; Menzies AM; Moreno D; Michielin O; Nathan P; Patel SP; Robert C; Schadendorf D; Lorigan PC; Scolyer RA; Tawbi HA; van de Wiel BA; Blank C; Long GV
Nat Med; 2023 Jun; 29(6):1310-1312. PubMed ID: 37193799
[No Abstract] [Full Text] [Related]
6. Neoadjuvant immunotherapy improves outlook in high-risk melanoma.
Nierengarten MB
Cancer; 2023 Jul; 129(13):1952. PubMed ID: 37300812
[No Abstract] [Full Text] [Related]
7. Finding the right combination for neoadjuvant therapy in high-risk, stage III melanoma.
Amaria R; Caffrey M
Am J Manag Care; 2019 Feb; 25(2 Spec No.):SP43-SP44. PubMed ID: 30776211
[No Abstract] [Full Text] [Related]
8. Neoadjuvant Treatments for Advanced Resectable Melanoma.
Liu JY; Lowe M
J Surg Oncol; 2019 Jan; 119(2):216-221. PubMed ID: 30589079
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Therapy for Melanoma.
Lowe MC; Kudchadkar RR
Surg Oncol Clin N Am; 2020 Jul; 29(3):445-453. PubMed ID: 32482319
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
